Log in to save to my catalogue

Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic...

Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1838744267

Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting

About this item

Full title

Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting

Publisher

Melbourne: News Bites Pty Ltd

Journal title

News Bites - Healthcare & Equipment, 2016

Language

English

Publication information

Publisher

Melbourne: News Bites Pty Ltd

More information

Alternative Titles

Full title

Horizon Pharma plc Presents Data on KRYSTEXXA (pegloticase) for the Management of Refractory Chronic Gout at the 2016 ACR/ARHP Annual Meeting

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_wirefeeds_1838744267

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_wirefeeds_1838744267

How to access this item